Ad2 - A Fully Integrated Clinical Trial Like System to Guarantee Persistence on Planned Hepatitis C Treatment: Evidence From the Real-World

Value in Health- United Kingdom

doi 10.1016/j.jval.2018.09.009

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Treatment Sequencing in Oncology: Balancing Clinical Trial and Real-World Evidence

Future Oncology
MedicineCancer ResearchOncology
2019English

HeartMate 3: Bridging From Clinical Trial Experience to Real World Use

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

Alemtuzumab in the Long-Term Treatment of Relapsing-Remitting Multiple Sclerosis: An Update on the Clinical Trial Evidence and Data From the Real World

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2017English

Expert Clinical Management of Autoimmune Hepatitis in the Real World

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Real World Studies Using Japanese Administrative Databases: Chronic Hepatitis C Treatment Pattern and Resource Use

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Association Between Vitamin D Levels and Treatment Response to Direct-Acting Antivirals in Chronic Hepatitis C: A Real-World Study

Gastroenterology Research
2018English

Cutting-Edge Research on Hepatitis C Treatment and the Clinical Perspectives

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2010English

Treatment of Hepatitis C Genotype 1 Infection in Germany: Effectiveness and Safety of Antiviral Treatment in a Real-World Setting

United European Gastroenterology Journal
OncologyGastroenterology
2017English

The Inclusion of Real World Evidence in Clinical Development Planning

Trials
MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy